NGS-Based RNA-Sequencing Market Insights Covering Sequencing Technologies Applications End Users and Regional Trends with Projected Growth to 2034

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global NGS-Based RNA-Sequencing Market Size, Share & Trends Analysis Report By Type (Targeted RNA Sequencing, mRNA Sequencing, Total RNA Sequencing, Single-cell RNA Sequencing (scRNA-Seq), De Novo Transcriptome Assembly , and Non-coding RNA Sequencing (miRNA, lncRNA, circRNA)), Workflow Component (Sequencing, Library Preparation & Sample Processing, Storage & Cloud Bioinformatics, and Data Analysis & Interpretation), Technology (Sequencing by Synthesis (SBS), Third-generation Sequencing (PacBio, ONT), Ion Semiconductor Sequencing, Nanopore Sequencing (Oxford Nanopore), and SOLiD & Pyrosequencing (legacy/declining)), Application (Precision Medicine, Drug Discovery & Development, Cancer Genomics, Disease Mechanism Studies, Biomarker Discovery, Single-Cell Transcriptomics in Immuno-Oncology, Plant and Microbial Transcriptomics), End-user (Pharmaceutical & Biotechnology Companies, Academic & Research Institutions, Contract Research Organizations (CROs), Government and Non-profit Organizations, Clinical & Diagnostic Laboratories),-Market Outlook And Industry Analysis 2034"

The Global NGS-Based RNA-Sequencing Market is valued at US$ 3.6 Bn in 2024 and it is expected to reach US$ 20.3 Bn by the year 2034 , with a CAGR of 19.2% during the forecast period of 2025-2034.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/3186

A sophisticated sequencing technique called next-generation sequencing (NGS) of ribonucleic acid (RNA) is used to detect and examine RNA in a study sample. Researchers and scientists may learn about and comprehend the entire collection of RNA molecules, or transcriptomes, thanks to NGS-based RNA sequencing. The information thus gathered is then utilized to investigate gene expression.

Researchers can utilize it to find new transcripts or possible mutations, which aids in their molecular-level analysis of biological processes. The growing need for transcriptome profiling, the growing use of precision medicine, and developments in high-throughput sequencing technologies are driving the NGS-based RNA-sequencing market's expansion.

Additionally, it is projected that the NGS-based RNA-sequencing market will expand within the forecast period due to the increasing number of product approvals and launches of RNA-sequencing platforms and consumables. The growing emphasis on transcriptome profiles and whole-genome sequencing research to create tailored medicine is driving the market for NGS-based RNA-sequencing.

Furthermore, their demand is rising due to the growing use of NGS-based RNA-sequencing in drug development, biomarker identification, and illness diagnostics. Market participants are concentrating on advancements in RNA sequencing technology, including BGI Genomics, Illumina, and Roche.

List of Prominent Players in the NGS-Based RNA-Sequencing Market:
• Agilent Technologies
• QIAGEN
• Illumina, Inc.
• Thermo Fisher Scientific
• Takara Bio Inc.
• 10x Genomics
• Oxford Nanopore Technologies
• Pacific Biosciences (PacBio)
• BGI Genomics
• Novogene Corporation
• Eurofins Genomics
• Bio-Rad Laboratories
• Genewiz (Azenta Life Sciences)
• Parse Biosciences
• PerkinElmer (Revvity)
• CD Genomics
• Fulgent Genetics
• Macrogen Inc.
• Element Biosciences

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-04

Market Dynamics:
Drivers-
The market for NGS-based RNA-sequencing is expanding rapidly due to several key trends and factors. First and foremost, the growing need for personalized medicine calls for sophisticated genomic analysis in order to customize therapies to each patient's unique genetic profile. The falling cost of sequencing technology is contributing to this trend by making RNA sequencing more accessible and economical for clinical and research purposes.

Additionally, the NGS-based RNA-sequencing market is being driven by the increase in cancer research projects since RNA sequencing provides unmatched insights into tumor biology and the discovery of new biomarkers. Because it helps understand plant genetics for increased crop yields and resilience, the growing use of RNA sequencing in agricultural biotechnology also offers profitable prospects.

Challenges:
There are numerous significant obstacles and difficulties facing the NGS-based RNA-sequencing Market. One major obstacle is the high expense of sequencing technology, which prevents smaller labs and institutions from using it. Larger, better-funded companies tend to dominate the market due to this financial barrier.

Furthermore, the intricacy of data interpretation and analysis necessitates specialized knowledge, which is not always easily accessible, causing a processing pipeline bottleneck. Additionally, the market lacks established techniques, which restricts repeatability between studies and causes results to vary. Navigating the patent landscape may be costly and time-consuming, which makes intellectual property issues an additional challenge.

Regional Trends:
The NGS-based RNA-sequencing market was dominated by the North American region in 2024. Numerous prestigious colleges, research institutions, and biotech businesses are part of North America's robust research infrastructure, especially in the US. The region is able to dominate the industry because of the climate that encourages innovation and the quick adoption of NGS-based RNA-sequencing technologies. Additionally, advanced research, development, and use of NGS-based RNA-sequencing are made possible by the substantial public and private investment in North America's biotechnology and healthcare sectors.

During the projected period, the NGS-based RNA-sequencing market is expected to develop at the highest CAGR in the Asia Pacific. Increased investment and government initiatives to upgrade healthcare infrastructure are helping the region's healthcare industry grow quickly. The employment of contemporary technology, like NGS-based RNA-sequencing, in research and diagnostics is encouraged by this growth.

Additionally, precision medicine-which uses genetic data to deliver patient-specific medications-is gaining importance in Asia Pacific nations. The significance of NGS-based RNA-sequencing in the investigation of genetic variations has led to its growing popularity.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customization/3186

Segmentation of NGS-Based RNA-Sequencing Market-
By Type-
• Targeted RNA Sequencing
• mRNA Sequencing
• Total RNA Sequencing
• Single-cell RNA Sequencing (scRNA-Seq)
• De Novo Transcriptome Assembly
• Non-coding RNA Sequencing (miRNA, lncRNA, circRNA)
By Workflow Component -
• Sequencing
• Library Preparation & Sample Processing
• Storage & Cloud Bioinformatics
• Data Analysis & Interpretation
By Technology-
• Sequencing by Synthesis (SBS)
• Third-generation Sequencing (PacBio, ONT)
• Ion Semiconductor Sequencing
• Nanopore Sequencing (Oxford Nanopore)
• SOLiD & Pyrosequencing (legacy/declining)
By Application-
• Precision Medicine
• Drug Discovery & Development
• Cancer Genomics
• Disease Mechanism Studies
• Biomarker Discovery
• Single-Cell Transcriptomics in Immuno-Oncology
• Plant and Microbial Transcriptomics
By End-user-
• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutions
• Contract Research Organizations (CROs)
• Government and Non-profit Organizations
• Clinical & Diagnostic Laboratories
By Region-
North America-
• The US
• Canada
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Mexico
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa

Read Overview Report- https://www.insightaceanalytic.com/report/ngs-based-rna-sequencing-market/3186

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 607 400-7072
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.